Page 2 - Oblte News Today

Belite Bio (NASDAQ:BLTE – Free Report) had its price target boosted by HC Wainwright from $55.00 to $59.00 in a research report report published on Monday, Benzinga reports. They currently have a buy rating on the stock. A number of other analysts have also weighed in on BLTE. SVB Securities started coverage on shares of […]

Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) saw unusually-high trading volume on Tuesday after HC Wainwright raised their price target on the stock from $55.00 to $59.00. HC Wainwright currently has a buy rating on the stock. Approximately 97,119 shares were traded during trading, an increase of 77% from the previous session’s volume of […]

Shares of Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) have earned an average rating of “Buy” from the six brokerages that are covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a buy rating. The average twelve-month price objective among brokerages that have covered the stock in the last year is […]

Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) shares saw an uptick in trading volume on Friday . 268,388 shares were traded during trading, an increase of 496% from the previous session’s volume of 45,016 shares.The stock last traded at $33.68 and had previously closed at $32.35. Analyst Upgrades and Downgrades BLTE has been the […]

Belite Bio (NASDAQ:BLTE – Get Free Report) and Foghorn Therapeutics (NASDAQ:FHTX – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, dividends, risk, valuation, earnings and institutional ownership. Institutional & Insider Ownership 3.8% of Belite […]

Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) was the target of a large growth in short interest during the month of August. As of August 31st, there was short interest totalling 37,500 shares, a growth of 7.1% from the August 15th total of 35,000 shares. Based on an average daily trading volume, of 81,900 […]

Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) shares saw unusually-high trading volume on Tuesday . Approximately 49,845 shares changed hands during trading, an increase of 32% from the previous session’s volume of 37,639 shares.The stock last traded at $34.72 and had previously closed at $35.30. Analyst Ratings Changes BLTE has been the topic of […]

Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) shares traded up 11.4% during trading on Thursday . The company traded as high as $24.75 and last traded at $24.73. 90,592 shares were traded during trading, an increase of 197% from the average session volume of 30,536 shares. The stock had previously closed at $22.19. Wall […]

Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) saw a large increase in short interest in the month of July. As of July 31st, there was short interest totalling 46,100 shares, an increase of 30.6% from the July 15th total of 35,300 shares. Based on an average trading volume of 56,500 shares, the short-interest ratio […]

HC Wainwright reiterated their buy rating on shares of Belite Bio (NASDAQ:BLTE – Free Report) in a research note published on Thursday, Benzinga reports. They currently have a $55.00 price target on the stock. A number of other research analysts have also commented on the stock. Leerink Partnrs restated an outperform rating on shares of […]